Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Cancer Res. 2009 Mar 3;69(6):2176–2179. doi: 10.1158/0008-5472.CAN-08-3151

Table 1.

Frequencies of germline CNP at 2p24.3 in prostate cancer cases and controls

Association test
Cases
Controls
% of deletion carrier
WW WD DD WW WD DD Cases Controls P-value
All cases
CAPS-GWAS 415 56 4 443 39 1 12.63% 8.28% 0.03
Remaining CAPS 2103 276 7 1078 129 6 11.86% 11.13% 0.52
JHH 1278 169 6 441 37 2 12.04% 8.13% 0.02
Total 3796 501 17 1962 205 9 12.01% 9.83% 0.009
Aggressive cases
CAPS-GWAS 415 56 4 443 39 1 12.92% 8.28% 0.03
Remaining CAPS 647 95 1 1078 129 6 12.88% 11.13% 0.23
JHH 849 110 6 441 37 2 12.02% 8.13% 0.02
Total 1911 261 11 1962 205 9 12.46% 9.83% 0.006
Non-aggressive cases
CAPS-GWAS 0 0 0 443 39 1 -- 8.28% --
Remaining CAPS 1456 181 6 1078 129 6 11.38% 11.13% 0.83
JHH 415 56 0 441 37 2 11.89% 8.13% 0.05
Total 1871 237 6 1962 205 9 11.49% 9.83% 0.08